Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1207 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Valoctocogene Roxaparvovec for Severe Haemophilia A	Valoctocogene Roxaparvovec (BMN 270)	Haemophilia A	Haematology	2020	View \| Download
Vamorolone for treating Duchenne muscular dystrophy	Vamorolone (VBP15)	Duchenne muscular dystrophy (DMD)	Genetic Disorders , Musculoskeletal System	2021	View \| Download
Vanzacaftor / tezacaftor / deutivacaftor for the treatment of cystic fibrosis	Deutivacaftor , Tezacaftor (VX-661) , Vanzacaftor	Cystic fibrosis	Genetic Disorders , Respiratory System	2023	View \| Download
Vedolizumab for treating active pouchitis	Vedolizumab (Entyvio; LDP-02; MLN0002)	Pouchitis	Gastroenterology	2022	View \| Download
Veliparib (ABT-888) with carboplatin and paclitaxel for advanced or metastatic non-squamous (current or former smokers) non-small cell lung cancer	Carboplatin (Paraplatin) , Paclitaxel (Taxol; paclitaxel albumin) , Veliparib (ABT-888; NSC 737664)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2017	View \| Download
Veliparib in addition to carboplatin and paclitaxel for epithelial ovarian, fallopian tube, or primary peritoneal cancer	Carboplatin (Paraplatin) , Paclitaxel (Taxol; paclitaxel albumin) , Veliparib (ABT-888; NSC 737664)	Epithelial ovarian cancer , Fallopian tube cancer , primary peritoneal cancer	Female Reproductive Cancer	2018	View \| Download
Veliparib in Combination with Carboplatin and Paclitaxel for Breast Cancer – First to Third Line	Carboplatin (Paraplatin) , Paclitaxel (Taxol; paclitaxel albumin) , Veliparib (ABT-888; NSC 737664)	Breast cancer	Breast Cancer	2017	View \| Download
Vemurafenib (Zelboraf) for BRAF V600 mutation positive melanoma; completely resected but at high risk of recurrence	Vemurafenib (Zelboraf; PLX4032; R7204; RO5185426; PLX-4032; RG7204)	Melanoma	Skin Cancer	2017	View \| Download
Venetoclax in addition to ibrutinib for relapsed mantle cell lymphoma – second-line and beyond	Ibrutinib (Imbruvica) , Venetoclax (Venclyxto; ABT-199; Venclexta; GDC-0199)	Mantle cell lymphoma	Haematological Cancer and Lymphomas	2020	View \| Download
Venetoclax in combination with a hypomethylating agent or low dose cytarabine for newly diagnosed acute myeloid leukaemia	hypomethylating agent , Low-dose cytarabine , Venetoclax (Venclyxto; ABT-199; Venclexta; GDC-0199)	Acute myeloid leukaemia (AML)	Haematological Cancer and Lymphomas	2018	View \| Download